Haemangiosarcoma of the Third Eyelid in Great Dane Dogs
World Small Animal Veterinary Association World Congress Proceedings, 2003
Nalinee Tuntivanich; Atichat Brahmasa; Pranee Tuntivanich; Anudep Rungsipipat
Department of Veterinary Surgery, Faculty of Veterinary Sciences, Chulalongkorn University
Bangkok, Thailand


The rare occurrence of haemangiosarcoma of the third eyelid in 2 Great Dane dogs which has never been previously reported especially in this breed of dog was presented.

Case History

Case 1

A dog was presented with a proliferative bright red mass, 0.4 x 0.8 x 0.4 cm. in size, on the palpebral aspect of the third eyelid. The mass had been developed for three months. Bleeding from the side of the mass was occasionally noticed. The mass was surgically removed. The recurrence of the mass at the same site had been observed in 4 months after the surgery. Amputation of the third eyelid was the second surgery. There was no occurrence within 12 months.

Case 2

A dark red mass was protruding out of the palpebral aspect of the third eyelid in a dog. The mass had been developed for six months. The surgical removal of the third eyelid was the treatment of choice. Evaluation of the patient at 12 months after the surgery was satisfactory.


Haemangioma more commonly involves the bulba conjunctiva than the third eyelid. Tumor of the third eyelid in the dog tends to occur most commonly at the leading margin and less commonly at the limbus. Amputation of the third eyelid is the treatment of choice.


Surgical removal of the haemangiosarcoma of the third eyelid could not prevent the recurrence of the mass. Amputation of the third eyelid was the only successful surgical treatment in 2 Great Dane dogs when early detection and diagnosis were made.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Nalinee Tuntivanich
Department of Veterinary Surgery
Faculty of Veterinary Sciences
Chulalongkorn University
Bangkok, Thailand

MAIN : Ophthalmology : Haemangiosarcoma
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.


777 W. Covell Blvd., Davis, CA 95616



  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357